Getagraph.com logo
S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(0.11%) $83.66
Gas
(-3.32%) $1.920
Gold
(0.30%) $2 349.60
Silver
(-0.43%) $27.52
Platinum
(0.42%) $924.40
USD/EUR
(0.32%) $0.935
USD/NOK
(0.67%) $11.02
USD/GBP
(0.13%) $0.800
USD/RUB
(-0.07%) $92.11

实时更新： Cassiopea SpA [SKIN.SW]

交易所: SIX 工业: Pharmaceuticals, Biotechnology & Life Sciences
最后更新时间1 Jan 1970 @ 08:00
25% discount on Stockinvest.us - Use code: Podcast

9.85% CHF 35.70

Live Chart Being Loaded With Signals

Commentary (1 Jan 1970 @ 08:00):

Cassiopea S.p.A., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing medical dermatology products worldwide. It offers Winlevi, an antiandrogen, which has completed Phase III clinical trial for the topical treatment of acne; Breezula, a topical antiandrogen that is in Phase II clinical trial to treat androgenic alopecia; CB-06-01, a topical antibiotic, which is in Phase II clinical trial for the treatment of acne, including strains resistant to other antibiotics; and CB-06-02, a novel integrin activator that has completed Phase II clinical trial to treat genital warts...

Stats
今日成交量 2 756.00
平均成交量 1 818.00
市值 0.00
Last Dividend CHF0 ( N/A )
Next Dividend CHF0 ( N/A )
P/E -28.13
ATR14 CHF0 (0.00%)

Cassiopea SpA 相关性

10 最正相关
10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Cassiopea SpA 财务报表

Annual 2020
营收: CHF0.00
毛利润: CHF-611 000 (0.00 %)
EPS: CHF-1.183
FY 2020
营收: CHF0.00
毛利润: CHF-611 000 (0.00 %)
EPS: CHF-1.183
FY 2019
营收: CHF0.00
毛利润: CHF-242 000 (0.00 %)
EPS: CHF-1.168
FY 2018
营收: CHF0.00
毛利润: CHF-311 000 (0.00 %)
EPS: CHF-1.264

Financial Reports:

No articles found.

Cassiopea SpA

Cassiopea S.p.A., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing medical dermatology products worldwide. It offers Winlevi, an antiandrogen, which has completed Phase III clinical trial for the topical treatment of acne; Breezula, a topical antiandrogen that is in Phase II clinical trial to treat androgenic alopecia; CB-06-01, a topical antibiotic, which is in Phase II clinical trial for the treatment of acne, including strains resistant to other antibiotics; and CB-06-02, a novel integrin activator that has completed Phase II clinical trial to treat genital warts. The company was formerly known as Cosmo Dermatos S.r.l. Cassiopea S.p.A. was founded in 2013 and is based in Lainate, Italy. As of December 2, 2021, Cassiopea S.p.A. operates as a subsidiary of Cosmo Pharmaceuticals N.V.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟；与所有市场信号一样，存在误差或错误的可能性。

实时交易信号不是绝对的，getagraph.com 对基于这些信号采取的任何行动概不负责，如《使用条款》中所述。这些信号是基于广泛的技术分析指标。